In view of recent evidence linking sulfate homeostasis to back pain and intervertebral disc disorder (7), our study identifies SLC26A1 as a potential target for modulation of musculoskeletal health. The gene discussed is SLC26A1; the disease is lumbar disk degenerative disorder.